PlainRecalls
FDA Drug Moderate Class II Ongoing

Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC - 60793-701-10, Syringe NDC - 60793-701-02

Reported: August 6, 2025 Initiated: July 10, 2025 #D-0544-2025

Product Description

Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC - 60793-701-10, Syringe NDC - 60793-701-02

Reason for Recall

CGMP Deviations; particulates identified during visual inspection

Details

Recalling Firm
Pfizer Inc.
Units Affected
50,855 2 mL vials
Distribution
Nationwide in the USA
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC - 60793-701-10, Syringe NDC - 60793-701-02. Recalled by Pfizer Inc.. Units affected: 50,855 2 mL vials.
Why was this product recalled?
CGMP Deviations; particulates identified during visual inspection
Which agency issued this recall?
This recall was issued by the FDA Drug on August 6, 2025. Severity: Moderate. Recall number: D-0544-2025.